← All insights▼
▼
Sponsor Alignment· Sponsor ↔ sector
Bill Cassidy (R) is primary sponsor of Pharmaceuticals & Biotech bill s415-117; Pharmaceuticals & Biotech is a top donor industry (5%)
The bill s415-117 would narrow the FDA's definition of "active ingredient" to "active moiety" for pharmaceutical drugs, affecting market exclusivity and review processes in the Pharmaceuticals & Biotech industry. Senator Bill Cassidy (R-LA) introduced this bill. Pharmaceuticals & Biotech contributed 5.4% of Cassidy's identifiable donor base ($0.47M), ranking 13th among donor industries in his party.
💊
Pharmaceuticals & Biotech
top donor sector
gave $469K
5% of their funding
▶
Bill Cassidy
R-LA · Senate
sponsored
industry: pharma
▶
📜
S415-117
their bill
5%
of their classified donations are from this sector
$469K
from Pharmaceuticals & Biotech
#13
most-funded by this sector in their party (of 265)
FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated June 26, 2026 · internal signal score 56/100.